BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 33069853)

  • 1. Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children.
    Plebani A; Meini A; Cattalini M; Lougaris V; Bugatti A; Caccuri F; Caruso A
    Clin Immunol; 2020 Dec; 221():108613. PubMed ID: 33069853
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterizing the differences between multisystem inflammatory syndrome in children and Kawasaki disease.
    Bar-Meir M; Guri A; Godfrey ME; Shack AR; Hashkes PJ; Goldzweig O; Megged O
    Sci Rep; 2021 Jul; 11(1):13840. PubMed ID: 34226639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kawasaki syndrome and Mycoplasma pneumoniae infection].
    Merlin E; Al Fatuhi H; Crost P
    Arch Pediatr; 2004 Aug; 11(8):972-3. PubMed ID: 15288092
    [No Abstract]   [Full Text] [Related]  

  • 4. Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings.
    Marzano AV; Cassano N; Moltrasio C; Verdoni L; Genovese G; Vena GA
    Dermatology; 2022; 238(1):35-43. PubMed ID: 34062530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 causes Kawasaki-like disease in children: Cases reported in Pakistan.
    Khan KS; Ullah I
    J Med Virol; 2021 Jan; 93(1):20-21. PubMed ID: 32706410
    [No Abstract]   [Full Text] [Related]  

  • 6. Multisystem inflammatory syndrome in neonates associated with SARS-CoV-2 infection, a different entity?
    Gámez-González LB; Escárcega-Juárez Ana Silvia AS; Aguilar-Soto DE; Colmenero Rascón M; García Espinosa AC; Yamazaki-Nakashimada MA
    J Neonatal Perinatal Med; 2023; 16(1):169-177. PubMed ID: 36314218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus disease 2019 (COVID-19): A systematic review of 133 Children that presented with Kawasaki-like multisystem inflammatory syndrome.
    Keshavarz P; Yazdanpanah F; Azhdari S; Kavandi H; Nikeghbal P; Bazyar A; Rafiee F; Nejati SF; Sadabad FE; Rezaei N
    J Med Virol; 2021 Sep; 93(9):5458-5473. PubMed ID: 33969513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Children: One Year after the Onset of the Pandemic in a High-Incidence Area.
    Fabi M; Filice E; Biagi C; Andreozzi L; Palleri D; Mattesini BE; Rizzello A; Gabrielli L; Ghizzi C; Di Luca D; Caramelli F; De Fanti A; Lanari M
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 and Mycoplasma pneumoniae: SARS-CoV-2 false positive or coinfection?
    Monte Serrano J; García-Gil MF; Cruañes Monferrer J; Aldea Manrique B; Prieto-Torres L; García García M; Matovelle Ochoa C; Ara-Martín M
    Int J Dermatol; 2020 Oct; 59(10):1282-1283. PubMed ID: 32767368
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical Kawasaki syndrome in COVID-19 infection: a case report of a multisystem inflammatory syndrome in a child (MIS-C).
    Sylverken J; Afari P; Martyn-Dickens C; Owusu SA; Oppong E; Akwetey F; Mensah E; Mahama H; Owusu SK; Antwi S
    Ghana Med J; 2021 Jun; 55(2 Suppl):64-67. PubMed ID: 35233117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-specific Mycoplasma pneumoniae pneumonia-associated myocardial damage in children.
    Li CM; Gu L; Yin SJ; Yang R; Xie Y; Guo XZ; Fu YX; Cheng D
    J Int Med Res; 2013 Oct; 41(5):1716-23. PubMed ID: 24026772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Inflammatory Multisystem Syndrome: Time to Collaborate.
    Kanthimathinathan HK; Scholefield BR
    J Pediatric Infect Dis Soc; 2021 Apr; 10(3):227-229. PubMed ID: 32945863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythema multiforme and Kawasaki disease associated with COVID-19 infection in children.
    Labé P; Ly A; Sin C; Nasser M; Chapelon-Fromont E; Ben Saïd P; Mahé E
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e539-e541. PubMed ID: 32455505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection in the context of Kawasaki disease and multisystem inflammatory syndrome in children.
    Folga BA; Karpenko CJ; Grygiel-Górniak B
    Med Microbiol Immunol; 2023 Feb; 212(1):3-12. PubMed ID: 36396785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kawasaki disease and Mycoplasma pneumoniae infection].
    Chemli J; Hassayoun S; Ketata S; Ajmi H; Ayeche H; Zouari N; Abroug S; Boujaafar N; Harbi A
    Med Mal Infect; 2010 Dec; 40(12):717-9. PubMed ID: 20650584
    [No Abstract]   [Full Text] [Related]  

  • 16. Kawasaki disease associated with Mycoplasma pneumoniae.
    Tang Y; Yan W; Sun L; Huang J; Qian W; Hou M; Lv H
    Ital J Pediatr; 2016 Sep; 42(1):83. PubMed ID: 27609267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel coronavirus infection and Kawasaki disease.
    Bitsadze VO; Grigoreva K; Khizroeva JK; Pervunina TM; Tsibizova VI; Tretyakova MV; Makatsariya AD
    J Matern Fetal Neonatal Med; 2022 Aug; 35(16):3044-3048. PubMed ID: 32731783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kawasaki disease shock syndrome in the COVID-19 pandemic.
    Gámez-González LB; Ramírez-López MJ; Colmenero-Rascón M; Yamazaki-Nakashimada MA
    Cardiol Young; 2022 Mar; 32(3):506-507. PubMed ID: 34278987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-morbidity of Kawasaki disease.
    Huang FL; Chang TK; Jan SL; Tsai CR; Wang LC; Lai MC; Chen PY
    Indian J Pediatr; 2012 Jun; 79(6):815-7. PubMed ID: 22057395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative SARS-CoV-2 Serology in Children With Multisystem Inflammatory Syndrome (MIS-C).
    Rostad CA; Chahroudi A; Mantus G; Lapp SA; Teherani M; Macoy L; Tarquinio KM; Basu RK; Kao C; Linam WM; Zimmerman MG; Shi PY; Menachery VD; Oster ME; Edupuganti S; Anderson EJ; Suthar MS; Wrammert J; Jaggi P
    Pediatrics; 2020 Dec; 146(6):. PubMed ID: 32879033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.